Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
The Goldman Sachs Group, Inc. (GS) - free report >>
Abercrombie & Fitch Company (ANF) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Goldman Sachs Group, Inc. (GS) - free report >>
Abercrombie & Fitch Company (ANF) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for January 20th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 20th:
CF Industries Holdings, Inc. (CF - Free Report) : This manufacturer and distributor of nitrogen fertilizers and other nitrogen products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 27.3% over the last 60 days.
CF Industries Holdings, Inc. Price and Consensus
CF Industries Holdings, Inc. price-consensus-chart | CF Industries Holdings, Inc. Quote
CF Industries’ shares gained 19.8% over the last one month compared with the S&P 500’s growth of 2.4%. The company possesses a Momentum Score of A.
CF Industries Holdings, Inc. Price
CF Industries Holdings, Inc. price | CF Industries Holdings, Inc. Quote
Navient Corporation (NAVI - Free Report) : This provider of education loan management and business processing solutions has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.
Navient Corporation Price and Consensus
Navient Corporation price-consensus-chart | Navient Corporation Quote
Navient’s shares gained 20.6% over the last one month. The company possesses a Momentum Score of A.
Navient Corporation Price
Navient Corporation price | Navient Corporation Quote
The Goldman Sachs Group, Inc. (GS - Free Report) : This investment banking, securities, and investment management company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.5% over the last 60 days.
The Goldman Sachs Group, Inc. Price and Consensus
The Goldman Sachs Group, Inc. price-consensus-chart | The Goldman Sachs Group, Inc. Quote
Goldman Sachs’ shares gained 21.5% over the last one month. The company possesses a Momentum Score of A.
The Goldman Sachs Group, Inc. Price
The Goldman Sachs Group, Inc. price | The Goldman Sachs Group, Inc. Quote
Abercrombie & Fitch Co. (ANF - Free Report) : This specialty retailer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 42.5% over the last 60 days.
Abercrombie & Fitch Company Price and Consensus
Abercrombie & Fitch Company price-consensus-chart | Abercrombie & Fitch Company Quote
Abercrombie & Fitch’s shares gained 17.9% over the last one month. The company possesses a Momentum Score of A.
Abercrombie & Fitch Company Price
Abercrombie & Fitch Company price | Abercrombie & Fitch Company Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>